|
ZA989389B
(en)
*
|
1997-11-14 |
2000-04-14 |
Lilly Co Eli |
Pyrrolo [3,2-b] pyridine processes and intermediates.
|
|
US5905084A
(en)
*
|
1997-11-14 |
1999-05-18 |
Eli Lilly And Company |
5-HTIF -agonists effective in treating migraine
|
|
US6133290A
(en)
*
|
1998-07-31 |
2000-10-17 |
Eli Lilly And Company |
5-HT1F agonists
|
|
GB9823845D0
(en)
*
|
1998-11-02 |
1998-12-23 |
Lilly Co Eli |
Pharmaceutical compounds
|
|
US6608079B1
(en)
|
1998-12-11 |
2003-08-19 |
Eli Lilly And Company |
Indole derivatives and their use as 5-HT1F agonists
|
|
WO2003059884A1
(en)
|
2001-12-21 |
2003-07-24 |
X-Ceptor Therapeutics, Inc. |
Modulators of lxr
|
|
US7482366B2
(en)
|
2001-12-21 |
2009-01-27 |
X-Ceptor Therapeutics, Inc. |
Modulators of LXR
|
|
TWI263497B
(en)
|
2002-03-29 |
2006-10-11 |
Lilly Co Eli |
Pyridinoylpiperidines as 5-HT1F agonists
|
|
ES2201899B1
(es)
*
|
2002-04-01 |
2005-06-01 |
Almirall Prodesfarma, S.A. |
Derivados de la azaindolilpiperidina como agentes antihistaminicos y antialergicos.
|
|
MXPA05011223A
(es)
|
2003-04-18 |
2006-01-26 |
Lilly Co Eli |
Compuestos de (piperidiniloxi)fenilo, (piperidiniloxi)piridinilo, (piperidinilsulfanil)fenilo y (piperidinilsulfanil)piridinilo como agonistas 5-htif.
|
|
UA82711C2
(en)
|
2003-09-12 |
2008-05-12 |
Эли Лилли Энд Компани |
Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists
|
|
CA2546754A1
(en)
*
|
2003-11-21 |
2005-06-09 |
Array Biopharma Inc. |
Akt protein kinase inhibitors
|
|
DE602004008338T2
(de)
|
2003-12-17 |
2008-05-29 |
Eli Lilly And Co., Indianapolis |
Substituierte (4-aminocyclohexen-1-yl) phenyl and (4-aminocyclohexen-1-yl) pyridinyl verbindungen als 5-ht1f agonisten
|
|
US8329701B2
(en)
|
2006-07-06 |
2012-12-11 |
Array Biopharma Inc. |
Dihydrofuro pyrimidines as AKT protein kinase inhibitors
|
|
US8063050B2
(en)
*
|
2006-07-06 |
2011-11-22 |
Array Biopharma Inc. |
Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
|
|
ATE532789T1
(de)
|
2006-07-06 |
2011-11-15 |
Array Biopharma Inc |
Dihydrothienopyrimidine als akt-proteinkinase- inhibitoren
|
|
EP2049500B1
(en)
*
|
2006-07-06 |
2011-09-07 |
Array Biopharma, Inc. |
Cyclopenta [d] pyrimidines as akt protein kinase inhibitors
|
|
CN103396409B
(zh)
|
2007-07-05 |
2015-03-11 |
阵列生物制药公司 |
作为akt蛋白激酶抑制剂的嘧啶基环戊烷
|
|
CN101918373B
(zh)
*
|
2007-07-05 |
2013-06-05 |
阵列生物制药公司 |
作为akt蛋白激酶抑制剂的嘧啶基环戊烷
|
|
US9409886B2
(en)
|
2007-07-05 |
2016-08-09 |
Array Biopharma Inc. |
Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
|
|
US8846683B2
(en)
|
2007-07-05 |
2014-09-30 |
Array Biopharma, Inc. |
Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
|
|
NZ586346A
(en)
*
|
2008-01-09 |
2012-02-24 |
Array Biopharma Inc |
Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
|
|
US8853216B2
(en)
*
|
2008-01-09 |
2014-10-07 |
Array Biopharma, Inc. |
Hydroxylated pyrimidyl cyclopentane as AKT protein kinase inhibitor
|
|
PL2413933T5
(pl)
|
2009-04-02 |
2021-10-18 |
Colucid Pharmaceuticals, Inc. |
2,4,6-trifluoro-N-[6-(1-metylopiperydyno-4-karbonylo)pirydyn-2-ylo]benzamid do leczenia migreny drogą doustną lub dożylną
|
|
US8697876B2
(en)
|
2010-04-02 |
2014-04-15 |
Colucid Pharmaceuticals, Inc. |
Compositions and methods of synthesis of pyridinolypiperidine 5-HT1F agonists
|
|
TR201815685T4
(tr)
|
2011-04-01 |
2018-11-21 |
Genentech Inc |
Kanser tedavisi için akt ve mek inhibe edici bileşiklerin kombinasyonları.
|
|
KR102021157B1
(ko)
|
2011-04-01 |
2019-09-11 |
제넨테크, 인크. |
Ａｋｔ 억제제 화합물 및 아비라테론의 조합물, 및 사용 방법
|
|
BG111544A
(bg)
|
2013-07-29 |
2015-01-30 |
Николай Цветков |
Субституирани бензамидни производни като in vitro mao-b инхибитори
|
|
LT3027603T
(lt)
*
|
2013-08-02 |
2018-08-10 |
Pfizer Inc. |
Heterobicikloarilo rorc2 inhibitoriai ir jų panaudojimo būdai
|
|
MA40759A
(fr)
|
2014-09-26 |
2017-08-01 |
Pfizer |
Modulateurs de rorc2 de type pyrrolopyridine substitué par un méthyle et trifluorométhyle et leurs procédés d'utilisation
|
|
DK3416964T3
(da)
*
|
2016-02-19 |
2021-02-22 |
Phoenix Molecular Designs |
6-Oxo-N-(1-(benzyl)-1H-pyrazol-4-YL)-6,7,8,9-tetrahydropyrido[3',2':4,5]pyrrolo[1,2-A]pyrazin-2-carboxamid-derivater som P90 ribosomal S6 kinase- (RSK-) hæmmere til behandling af cancer
|
|
WO2020038435A1
(en)
|
2018-08-24 |
2020-02-27 |
Sunshine Lake Pharma Co., Ltd. |
Pyridinylmethylenepiperidine derivatives and uses thereof
|
|
TWI826514B
(zh)
|
2018-09-04 |
2023-12-21 |
美商美國禮來大藥廠 |
用於預防偏頭痛之拉米迪坦(lasmiditan)長期夜間投藥
|
|
US12378245B2
(en)
|
2019-02-11 |
2025-08-05 |
Phoenix Molecular Designs |
Crystalline forms of an RSK inhibitor
|
|
TWI776175B
(zh)
|
2019-07-09 |
2022-09-01 |
美商美國禮來大藥廠 |
大規模製備2,4,6-三氟-n-[6-(1-甲基-哌啶-4-羰基)-吡啶-2-基]-苯甲醯胺半琥珀酸鹽的方法及中間體，以及2,4,6-三氟-n-[6-(1-甲基-哌啶-4-羰基)-吡啶-2-基]-苯甲醯胺醋酸鹽之製備
|